"These GABAB PAM assets reflect years of world-class research in allosteric modulation and build on a biological approach clinically validated by baclofen,” said Tim Dyer, CEO of Addex Therapeutics.
Robo.ai Inc. announced that a groundbreaking ceremony was held in Umm Al Quwain for Phase I of the ALIF Holding Group Industrial Park. The first of the Industrial Park's three planned phases will have ...
AI token costs have gone from a minor technology detail to a board-level budget problem in under a year. Twelve months ago, ...